This complements previous studies on the role of LMP1 in activating CD4+ and CD8+ CTLs, which primarily focused on their responses to LMP1/2A expressing B cell lymphomas (12, 15, 16). Here, PDLIM7 is linked to B-cell non-Hodgkin lymphoma.